These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16420726)

  • 21. Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group.
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R189-95. PubMed ID: 8556102
    [No Abstract]   [Full Text] [Related]  

  • 22. Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis.
    Katz LH; Zelazny A; Scharf S; Hourvitz A; Asor N; Arbeli Y; Yust-Katz S; Smollan-Fredman G; Gdalevich M
    Clin Microbiol Infect; 2007 Sep; 13(9):943-6. PubMed ID: 17635531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.
    Purcell B; Samuelsson S; Hahné SJ; Ehrhard I; Heuberger S; Camaroni I; Charlett A; Stuart JM
    BMJ; 2004 Jun; 328(7452):1339. PubMed ID: 15178612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam.
    ; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A
    Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
    Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
    Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of secondary cases of meningococcal disease in Denmark.
    Samuelsson S; Hansen ET; Osler M; Jeune B
    Epidemiol Infect; 2000 Jun; 124(3):433-40. PubMed ID: 10982067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccine coverage survey per cluster sampling after an antimeningococcal mass vaccination campaign at Niamey, Niger in 2000].
    de Chabalier F; Garba A; Chippaux JP
    Sante; 2001; 11(3):173-6. PubMed ID: 11641081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Meningococcal vaccination: which one? When? Why?].
    Rosenheim M
    Rev Prat; 2004 Mar; 54(5):512-8. PubMed ID: 15176510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprophylaxis fails to prevent a second case of meningococcal disease in a day nursery.
    Cartwright KA; Hunt D; Fox A
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R199. PubMed ID: 8556104
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemic meningococcal disease in an elementary-school classroom.
    Feigin RD; Baker CJ; Herwaldt LA; Lampe RM; Mason EO; Whitney SE
    N Engl J Med; 1982 Nov; 307(20):1255-7. PubMed ID: 6813733
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk of secondary meningococcal disease in health-care workers.
    Gilmore A; Stuart J; Andrews N
    Lancet; 2000 Nov; 356(9242):1654-5. PubMed ID: 11089828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic and socioeconomic variation in meningococcal disease: a rural/urban comparison.
    Olowokure B; Onions H; Patel D; Hooson J; O'Neill P
    J Infect; 2006 Jan; 52(1):61-6. PubMed ID: 16368462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of transmitting meningococcal infection by transient contact on aircraft and other transport.
    Rachael T; Schubert K; Hellenbrand W; Krause G; Stuart JM
    Epidemiol Infect; 2009 Aug; 137(8):1057-61. PubMed ID: 19296869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of secondary cases of invasive meningococcal infection: role of chemoprophylaxis and vaccination].
    Chuard C; Regamey C
    Rev Med Suisse Romande; 2003 Mar; 123(3):151-4. PubMed ID: 15095699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community outbreak of group B meningococcal disease in southwest France--December 2008 to September 2009.
    Delisle E; Larrieu S; Simões J; Laylle N; De Pommerol M; Taha MK; Termignon JL; Parent du Châtelet I
    Euro Surveill; 2010 Sep; 15(37):. PubMed ID: 20929645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.
    Arnold R; Galloway Y; McNicholas A; O'Hallahan J
    Vaccine; 2011 Sep; 29(40):7100-6. PubMed ID: 21803101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Invasive meningococcal disease in Opolskie Voivodeship between 2005-2010].
    Posmyk U; Hryniewicz W; Skoczyńska A; Kumala R
    Pol Merkur Lekarski; 2012 May; 32(191):287-92. PubMed ID: 22779333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.